Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2012, Article ID 147413, 5 pages
http://dx.doi.org/10.1155/2012/147413
Review Article

Ustekinumab in Psoriasis Immunopathology with Emphasis on the Th17-IL23 Axis: A Primer

1Department of Dermatopathology, University Hospital of Liège, 4000 Liège, Belgium
2Faculty of Medicine, University of Franche-Comté, 25000 Besançon, France
3Department of Dermatology, University Hospital of Besançon, 25000 Besançon, France
4Inserm Research Unit U645, IFR133, 25000 Besançon, France

Received 31 January 2012; Revised 5 March 2012; Accepted 5 March 2012

Academic Editor: Enzo Berardesca

Copyright © 2012 Pascale Quatresooz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Pascale Quatresooz, Trinh Hermanns-Lê, Gérald E. Piérard, Philippe Humbert, Philippe Delvenne, and Claudine Piérard-Franchimont, “Ustekinumab in Psoriasis Immunopathology with Emphasis on the Th17-IL23 Axis: A Primer,” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 147413, 5 pages, 2012. https://doi.org/10.1155/2012/147413.